Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 775 participants.

Also called NCT02921230

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 775 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02921230
Other papers using this trial's data
  • Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial Circulation, 2022-11-22 DOI, PubMed 36254728

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02921230. Randomized; single masking; primary purpose treatment. Start 2016-10-25 (actual); primary completion 2021-07-02 (actual). Results posted on 2024-10-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
Acronym
EMINENT
Condition
Arterial Occlusive Diseases
Condition
Atherosclerosis
Condition
Vascular Diseases
Condition
Arteriosclerosis
Intervention (Device)
Peripheral stenting
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct02921230
Content hash
b344887501f4535282d8adc431f7b9e98a68e8190d75e8f35f4417adf2ad62c9